Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

Trial Profile

Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Acamprosate (Primary)
  • Indications Alcoholism; Psychotic disorders; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2016 Number of treatment arms changed from one to two, study design changed from single to parallel assignment as reported by ClinicalTrials.gov.
    • 14 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top